You are here: Industry Insights > FDB

News List

FDB Launches Clinical Decision Support Analytics Solution americanpharmaceuticalreview
August 10, 2021
FDB announced the launch of FDB CDS Analytics™ at the 2021 HIMSS Global Conference & Exhibition in Las Vegas. The software solution enables healthcare organizations to easily identify, monitor and customize clinical decision support (CDS) in their ...
Fujifilm Diosynth Biotechnologies to expand biologics manufacturing capacity cphi-online
July 01, 2021
As part of $850 million investment package, CDMO will double US cell culture production for recombinant vaccines and increase UK gene therapy production tenfold.
Researchers link to facilitate cheaper biologics pharmatimes
April 07, 2021
The University of Edinburgh and FUJIFILM Diosynth Biotechnologies UK (FDB) are leading an £8.7 million, five-year research collaboration to develop more cost-effective ways to make modern antibody-based medicines.
Argonaut Manufacturing Services Completes First cGMP Run contractpharma
November 09, 2020
New automated aseptic fill/finish line for clinical and commercial use was recently approved by regulators.
FDB Approves Argonaut’s Facility contractpharma
October 15, 2020
The California Department of Public Health, Food and Drug Branch (FDB) has inspected and approved Argonaut Manufacturing Services’ new Drug Product Manufacturing facility, permitting Argonaut to manufacture and ship pharmaceutical products.
FUJIFILM Diosynth Licenses OXGENE's AAV system contractpharma
April 24, 2020
Aims to deliver gene therapy products to clients with an approximate 25% lead-time reduction.
FUJIFILM Diosynth Appoints Head of NC Ops contractpharma
March 18, 2020
Christine Vannais brings more than 20 years of experience and will serve as chief operating officer.
Fujifilm Diosynth Breaks Ground in UK contractpharma
March 13, 2020
Fujifilm Diosynth Biotechnologies (FDB), a cGMP contract development and manufacturing organization (CDMO) supporting its partners in the biopharmaceutical industry ...
FUJIFILM Diosynth Biotechnologies Appoints CEO contractpharma
March 10, 2020
Steve Bagshaw, chief executive officer of FUJIFILM Diosynth Biotechnologies (FDB), has decided to retire from his current position, effective April 1, 2020.
FDB Releases Opioid Risk Management Drug Knowledge to Reduce the Risk of Opioid-Related Overdose and biospace
March 16, 2018
FDB announced the release of the FDB Opioid Risk Management Module™ that helps reduce the risk of opioid-related overdose and addiction potential.